A national specialized service in England for atypical haemolytic uraemic syndrome-the first year's experience.
about
Critical appraisal of eculizumab for atypical hemolytic uremic syndromeThe role of ADAMTS-13 activity and complement mutational analysis in differentiating acute thrombotic microangiopathiesMonitoring of complement activation biomarkers and eculizumab in complement-mediated renal disorders.Thrombotic Microangiopathy in Inverted Formin 2-Mediated Renal Disease.Monoclonal gammopathy of renal significance triggering atypical haemolytic uraemic syndrome.Early eculizumab use in atypical haemolytic uraemic syndrome in a Jehovah's Witness refusing blood productsCurrent evidence on the discontinuation of eculizumab in patients with atypical haemolytic uraemic syndrome.Type I interferon causes thrombotic microangiopathy by a dose-dependent toxic effect on the microvasculature.Pathogenic Variants in Complement Genes and Risk of Atypical Hemolytic Uremic Syndrome Relapse after Eculizumab Discontinuation.Rare genetic variants in Shiga toxin-associated haemolytic uraemic syndrome: genetic analysis prior to transplantation is essential.Complement C5-inhibiting therapy for the thrombotic microangiopathies: accumulating evidence, but not a panacea.Factor H autoantibody is associated with atypical hemolytic uremic syndrome in children in the United Kingdom and IrelandMultiple centre evaluation study of ADAMTS13 activity and inhibitor assays.Long-term outcomes of the Atypical Hemolytic Uremic Syndrome after kidney transplantation treated with eculizumab as first choice.Safety and effectiveness of restrictive eculizumab treatment in atypical haemolytic uremic syndrome.Hemolytic Uremic Syndrome in Pregnancy and Postpartum.Diseases of complement dysregulation-an overview.Thrombotic Microangiopathy and the Kidney.The Differential Diagnosis and Treatment of Thrombotic Microangiopathies.Complement-mediated renal diseases after kidney transplantation - current diagnostic and therapeutic options in and recurrent diseasesThrombotic microangiopathy after renal transplantation: Current insights in and recurrent disease
P2860
Q26750692-F4343B8B-7A62-4FA3-9E73-5199647B3DBCQ33427495-6E96EB20-04E2-4DD2-9AA1-D397D7F6A0BEQ33436307-CA4F028D-B99F-44DF-A704-D4E5820F9E1BQ33437631-6538B620-4A0D-4F8E-B5A7-8D3197961151Q33439114-D89BC55B-CE46-4067-9AEF-AD9D79BCF10CQ33442901-07BB4D32-C35B-4920-8A40-9609750E06AEQ33783126-4021C8F2-009D-4029-9637-913726E46132Q37508060-A2308086-37AD-4874-BED0-377A0ADA2279Q39229604-0E91C4D9-D0DA-4497-AF32-6AED824270D9Q40075347-83A5F2E1-D7C9-47D8-BF57-1A8B20691AD2Q42086661-E97DE68C-D18E-41C8-978F-A9274F89D3B2Q42650328-10831FBE-88DF-4AA2-A59C-0455CBABC01CQ45873988-C7239782-1A35-40E2-8593-4ABDF4DF13A9Q47129863-9D986D96-3206-4D74-A37D-285D2D0E1A2AQ47225732-62470BDB-8828-4FB1-8604-95A893A78BADQ47736433-65D3DFE8-2DF9-41BA-B212-EE02C3EDAF6DQ48256943-63012FDD-C244-419F-AF2D-95CC360DED62Q50085453-DEB05198-F283-4371-97E6-DB08B42D8F6DQ55177523-1B7AD066-B04E-4F9D-A0BA-41E53075BFC6Q58120548-0746586F-8150-4A6D-BB6F-65165F4AD321Q58754943-C7A0F5F9-C63F-40DD-8E73-763829C94178
P2860
A national specialized service in England for atypical haemolytic uraemic syndrome-the first year's experience.
description
2015 nî lūn-bûn
@nan
2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
A national specialized service ...... e-the first year's experience.
@ast
A national specialized service ...... e-the first year's experience.
@en
type
label
A national specialized service ...... e-the first year's experience.
@ast
A national specialized service ...... e-the first year's experience.
@en
prefLabel
A national specialized service ...... e-the first year's experience.
@ast
A national specialized service ...... e-the first year's experience.
@en
P2093
P2860
P356
P1476
A national specialized service ...... e-the first year's experience.
@en
P2093
N S Sheerin
T H J Goodship
P2860
P356
10.1093/QJMED/HCV082
P407
P577
2015-04-21T00:00:00Z